Allergan Rivals' Eyelash Treatments Are Drugs, Court Rules
A California federal judge on Thursday granted summary judgment to Allergan Inc. on unfair competition claims over the alleged marketing of copycat versions of its eyelash treatment Latisse, ruling the rival...To view the full article, register now.
Already a subscriber? Click here to view full article